CN109876058A - A kind of pharmaceutical composition and preparation method thereof for treating anaphylactoid purpura - Google Patents

A kind of pharmaceutical composition and preparation method thereof for treating anaphylactoid purpura Download PDF

Info

Publication number
CN109876058A
CN109876058A CN201910331182.3A CN201910331182A CN109876058A CN 109876058 A CN109876058 A CN 109876058A CN 201910331182 A CN201910331182 A CN 201910331182A CN 109876058 A CN109876058 A CN 109876058A
Authority
CN
China
Prior art keywords
parts
tea oil
pharmaceutical composition
treating
anaphylactoid purpura
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201910331182.3A
Other languages
Chinese (zh)
Inventor
陈琳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tongren University
Original Assignee
Tongren University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tongren University filed Critical Tongren University
Priority to CN201910331182.3A priority Critical patent/CN109876058A/en
Publication of CN109876058A publication Critical patent/CN109876058A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention provides a kind of pharmaceutical compositions and preparation method thereof for treating anaphylactoid purpura, are related to technical field of traditional Chinese medicines.It is a kind of for treating the pharmaceutical composition of anaphylactoid purpura, be mainly made of raw material, according to parts by weight, raw material includes 100~180 parts of ovate neolepisorus herb, 75~120 parts of tea oil.To have the function of clearing heat and detoxicating, antibacterial anti-inflammatory, cooling blood and hemostasis after ovate neolepisorus herb and tea oil compatibility;Anaphylactoid purpura can be effectively treated, and uneasy to recur.A kind of preparation method of aforementioned pharmaceutical compositions mixes ovate neolepisorus herb and tea oil.This method is at low cost, simple and easy, being capable of industrialization large-scale production.

Description

A kind of pharmaceutical composition and preparation method thereof for treating anaphylactoid purpura
Technical field
The present invention relates to technical field of traditional Chinese medicines, and in particular to a kind of pharmaceutical composition for treating anaphylactoid purpura and Preparation method.
Background technique
Anaphylactoid purpura is tiny artery and capillary hemorrhage caused by a kind of vasculitis, is mainly shown as purpura, abdomen Bitterly, arthralgia and renal damage etc., the cause of disease is more complex, and the allergy object such as pathogenic infection, drug or pollen may cause, 7-14 Year is the disease high-incidence season.
China's treatment anaphylactoid purpura is frequently with antalgesic, solution spasm medicine, antihistamine, anticoagulant medicine etc., Chinese medicine at present Treatment then mostly uses oral traditional Chinese medicine preparation.After the Western medicine or Chinese materia medica preparation of above-mentioned higher cost, anaphylactoid purpura is still It is easy recurrence.
Summary of the invention
The purpose of the present invention is to provide a kind of for treating the pharmaceutical composition of anaphylactoid purpura, this pharmaceutical composition energy Enough sufficiently treatment anaphylactoid purpuras, and the case where be not in recurrence;Cost is relatively low simultaneously.
Another object of the present invention is to provide a kind of for treating the preparation method of the pharmaceutical composition of anaphylactoid purpura, Preparation method is simple for this, strong operability.
The present invention solves its technical problem and adopts the following technical solutions to realize.
The present invention proposes a kind of for treating the pharmaceutical composition of anaphylactoid purpura, is mainly made of raw material, by weight Number meter, raw material includes 100~180 parts of ovate neolepisorus herb, 75~120 parts of tea oil.
The present invention propose it is a kind of above-mentioned for treating the preparation method of the pharmaceutical composition of anaphylactoid purpura, by ovate neolepisorus herb and Tea oil mixing.
A kind of beneficial effect of pharmaceutical composition for treating anaphylactoid purpura proposed by the present invention and preparation method thereof It is:
It is a kind of to be mainly made of raw material for treating the pharmaceutical composition of anaphylactoid purpura, according to parts by weight, raw material packet Include 100~180 parts of ovate neolepisorus herb, 75~120 parts of tea oil.Ovate neolepisorus herb is fern Polypodiaceae shield Cyclosorus plant shield fern also known as west wind Sword, single leaf fan fern, have the effect of clearing heat and promoting diuresis, cooling blood and hemostasis, can pick herb or leaf uses.Tea oil, by camellia seed pressure It squeezes and obtains, containing a variety of fatty acid such as oleic acid, linoleic acid, linolenic acids, there is the effect of clearing heat and detoxicating, antibacterial anti-inflammatory.By ovate neolepisorus herb And have the function of clearing heat and detoxicating, antibacterial anti-inflammatory, cooling blood and hemostasis after tea oil compatibility;Anaphylactoid purpura can be effectively treated, and It is uneasy to recur.
It is a kind of above-mentioned for treating the preparation method of the pharmaceutical composition of anaphylactoid purpura, ovate neolepisorus herb and tea oil are mixed. This method is at low cost, simple and easy, being capable of industrialization large-scale production.
Specific embodiment
It in order to make the object, technical scheme and advantages of the embodiment of the invention clearer, below will be in the embodiment of the present invention Technical solution be clearly and completely described.The person that is not specified actual conditions in embodiment, according to normal conditions or manufacturer builds The condition of view carries out.Reagents or instruments used without specified manufacturer is the conventional production that can be obtained by commercially available purchase Product.
Below to a kind of pharmaceutical composition for treating anaphylactoid purpura of the embodiment of the present invention and preparation method thereof into Row illustrates.
The present embodiment it is a kind of for treating the pharmaceutical composition of anaphylactoid purpura, be mainly made of raw material, by weight Number meter, raw material includes 100~180 parts of ovate neolepisorus herb, 75~120 parts of tea oil.
Ovate neolepisorus herb is that fern Polypodiaceae shield Cyclosorus plant shield fern also known as west wind sword, single leaf fan fern, have clearing heat and promoting diuresis, The effect of cooling blood and hemostasis, can pick herb or leaf uses.
Tea oil is squeezed by camellia seed and obtain, containing a variety of fatty acid such as oleic acid, linoleic acid, linolenic acid, with it is clearing heat and detoxicating, The effect of antibacterial anti-inflammatory.
To have the function of clearing heat and detoxicating, antibacterial anti-inflammatory, cooling blood and hemostasis after ovate neolepisorus herb and tea oil compatibility;It can effectively control Anaphylactoid purpura is treated, and uneasy to recur.
Preferably, raw material includes 120~160 parts of ovate neolepisorus herb, 80~100 parts of tea oil.
It is further preferable that raw material includes 150 parts of ovate neolepisorus herb, 100 parts of tea oil.By inventor's the study found that matching at this Than under, the effect of the medicine composite for curing anaphylactoid purpura is best.
It should be noted that in the present embodiment, the density of tea oil is 0.8~1.3g/ml.
In preferably a kind of embodiment of the present embodiment, ovate neolepisorus herb selects herb or leaf.
The present embodiment additionally provides a kind of preparation method of above-mentioned pharmaceutical composition for being used to treat anaphylactoid purpura, will be big Golden knife and tea oil mixing.This method is simple and easy, being capable of industrialization large-scale production.
Preferably, it is mixed again with ovate neolepisorus herb after first heating tea oil.Medicine group can be significantly improved after first tea oil is heated Close the curative effect of object.
Preferably, tea oil is heated to 50 DEG C~70 DEG C.Within this temperature range, will not destroy in raw material it is effective at Point, improve drug effect.It is further preferable that tea oil is heated to 60 DEG C.
It is emphasized that in the present embodiment it is preferred to tea oil is heated using the equipment with a thermometer, with stringent Control the temperature of tea oil.
Preferably, ovate neolepisorus herb is crushed before ovate neolepisorus herb and tea oil are mixed.Preferably, ovate neolepisorus herb is crushed to 60~ 100 mesh.First its effective ingredient can be made fully to mix with tea oil ovate neolepisorus herb crushing.
The present embodiment additionally provides a kind of specific treatment method of pharmaceutical composition and step for preferably treating anaphylactoid purpura Suddenly are as follows:
The first step picks ovate neolepisorus herb herb or leaf, smashs to pieces, wrapped with gauze or cotton.
Second step takes tea oil, put be heated on charcoal fire or electric furnace 55 degrees centigrades (actual temp regard patient skin, Need to there are boiling hot feeling but not injury skin).
Pack heat release oil the inside is warmed 10s or more by third step.Then there is skin at purpura with the pack point touching of heat, such as This puts repeatedly applies repeatedly, 3 times a day, needs to change new drug every time, more than continuous January.
Feature and performance of the invention are described in further detail with reference to embodiments.
Embodiment 1
It is a kind of to be mainly made of raw material for treating the pharmaceutical composition of anaphylactoid purpura, according to parts by weight, raw material packet Include 100 parts of ovate neolepisorus herb, 75 parts of tea oil.
The preparation method of aforementioned pharmaceutical compositions: ovate neolepisorus herb and tea oil are mixed.
Embodiment 2
It is a kind of to be mainly made of raw material for treating the pharmaceutical composition of anaphylactoid purpura, according to parts by weight, raw material packet Include 180 parts of ovate neolepisorus herb, 120 parts of tea oil.
The preparation method of aforementioned pharmaceutical compositions: it after tea oil is first heated to 55 DEG C, then mixes with smashed ovate neolepisorus herb.
Embodiment 3
It is a kind of to be mainly made of raw material for treating the pharmaceutical composition of anaphylactoid purpura, according to parts by weight, raw material packet Include 120 parts of ovate neolepisorus herb, 80 parts of tea oil.
The preparation method of aforementioned pharmaceutical compositions: it after tea oil is first heated to 60 DEG C, then mixes with smashed ovate neolepisorus herb.
Embodiment 4
It is a kind of to be mainly made of raw material for treating the pharmaceutical composition of anaphylactoid purpura, according to parts by weight, raw material packet Include 160 parts of ovate neolepisorus herb, 100 parts of tea oil.
The preparation method of aforementioned pharmaceutical compositions: it after tea oil is first heated to 70 DEG C, then mixes with smashed ovate neolepisorus herb.
Embodiment 5
It is a kind of to be mainly made of raw material for treating the pharmaceutical composition of anaphylactoid purpura, according to parts by weight, raw material packet Include 150 parts of ovate neolepisorus herb, 100 parts of tea oil.
The preparation method of aforementioned pharmaceutical compositions: it after tea oil is first heated to 55 DEG C, then mixes with smashed ovate neolepisorus herb.
Embodiment 6
It is a kind of to be mainly made of raw material for treating the pharmaceutical composition of anaphylactoid purpura, according to parts by weight, raw material packet Include 120 parts of ovate neolepisorus herb, 100 parts of tea oil.
The preparation method of aforementioned pharmaceutical compositions: it after tea oil is first heated to 60 DEG C, then mixes with smashed ovate neolepisorus herb.
Embodiment 7
It is a kind of to be mainly made of raw material for treating the pharmaceutical composition of anaphylactoid purpura, according to parts by weight, raw material packet Include 110 parts of ovate neolepisorus herb, 90 parts of tea oil.
The preparation method of aforementioned pharmaceutical compositions: it after tea oil is first heated to 65 DEG C, then mixes with smashed ovate neolepisorus herb.
Embodiment 8
It is a kind of to be mainly made of raw material for treating the pharmaceutical composition of anaphylactoid purpura, according to parts by weight, raw material packet Include 165 parts of ovate neolepisorus herb, 80 parts of tea oil.
The preparation method of aforementioned pharmaceutical compositions: it after tea oil is first heated to 50 DEG C, then mixes with smashed ovate neolepisorus herb.
Typical case 1:
Chen, Guizhou Song Taoxian people, male, 10 months 2 years old when illness.In April, 2018, patient throw from bicycle and lead Cause scrotum etc. redness, abdominal pain.It is checked to township hospital and buys medicine treatment, and converted wine with rural area herbal medicine and apply red and swollen position, two Its rear foot bottom, shank, foot bow out existing blood cake.After enter the county hospital Song Tao, hospital considers that tumble injury row is infused anti-inflammatory, one week The red and swollen discharge that disappears afterwards.Discharge same day evening disease relapse, abdominal pain aggravate, foot enlargement, on foot blood cake in flakes, some hairs of blood cake It is bright.Enter the inspection of Tongren City the People's Hospital later and is diagnosed as anaphylactoid purpura, and hospitalization, row Amoxicillin, mountain LiangEqual medicines Object one week treatment, the swelling simultaneously of purpura lighter mitigates, but abdominal pain is serious always, and it is invalid to be relieved pain with hormone, and discharge turns Chongqing Army hospital, one week treatment.Abdominal pain disappears, and purpura also disappears substantially, leaves hospital.After discharge only two days again there is purpura, gradually plus Weight, the pharmaceutical composition provided using the present embodiment 5, continuous treatment one month, purpura completely disappears, and no longer recurs in 1 year.
To sum up, pharmaceutical composition provided by the invention, the effect for treating anaphylactoid purpura is good, is not in the feelings of recurrence Condition, and it is at low cost, preparation method is simple, is very beneficial to industrialization large-scale production.
Embodiments described above is a part of the embodiment of the present invention, instead of all the embodiments.Reality of the invention The detailed description for applying example is not intended to limit the range of claimed invention, but is merely representative of selected implementation of the invention Example.Based on the embodiments of the present invention, obtained by those of ordinary skill in the art without making creative efforts Every other embodiment, shall fall within the protection scope of the present invention.

Claims (9)

1. a kind of for treating the pharmaceutical composition of anaphylactoid purpura, which is characterized in that be mainly made of raw material, in parts by weight Meter, the raw material includes 100~180 parts of ovate neolepisorus herb, 75~120 parts of tea oil.
2. according to claim 1 for treating the pharmaceutical composition of anaphylactoid purpura, which is characterized in that the raw material packet Include 120~160 parts of the ovate neolepisorus herb, 80~100 parts of the tea oil.
3. according to claim 2 for treating the pharmaceutical composition of anaphylactoid purpura, which is characterized in that the raw material packet Include 150 parts of the ovate neolepisorus herb, 100 parts of the tea oil.
4. according to claim 1-3 for treating the pharmaceutical composition of anaphylactoid purpura, which is characterized in that institute It states ovate neolepisorus herb and selects herb or leaf.
5. a kind of such as according to claim 1-3 for treating the preparation side of the pharmaceutical composition of anaphylactoid purpura Method, which is characterized in that mix the ovate neolepisorus herb and the tea oil.
6. according to claim 5 for treating the preparation method of the pharmaceutical composition of anaphylactoid purpura, which is characterized in that It will first be mixed again with the ovate neolepisorus herb after tea oil heating.
7. according to claim 6 for treating the preparation method of the pharmaceutical composition of anaphylactoid purpura, which is characterized in that The tea oil is heated to 50 DEG C~70 DEG C.
8. according to claim 5 for treating the preparation method of the pharmaceutical composition of anaphylactoid purpura, which is characterized in that Before the ovate neolepisorus herb and the tea oil are mixed, the ovate neolepisorus herb is crushed.
9. according to claim 8 for treating the preparation method of the pharmaceutical composition of anaphylactoid purpura, which is characterized in that The ovate neolepisorus herb is crushed to 60~100 mesh.
CN201910331182.3A 2019-04-23 2019-04-23 A kind of pharmaceutical composition and preparation method thereof for treating anaphylactoid purpura Withdrawn CN109876058A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910331182.3A CN109876058A (en) 2019-04-23 2019-04-23 A kind of pharmaceutical composition and preparation method thereof for treating anaphylactoid purpura

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910331182.3A CN109876058A (en) 2019-04-23 2019-04-23 A kind of pharmaceutical composition and preparation method thereof for treating anaphylactoid purpura

Publications (1)

Publication Number Publication Date
CN109876058A true CN109876058A (en) 2019-06-14

Family

ID=66938251

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910331182.3A Withdrawn CN109876058A (en) 2019-04-23 2019-04-23 A kind of pharmaceutical composition and preparation method thereof for treating anaphylactoid purpura

Country Status (1)

Country Link
CN (1) CN109876058A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115448927A (en) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 Epinastine hydrobromide crystal form II and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
江苏新医学院编: "《中药大辞典》", 31 May 1986, 上海科学技术出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115448927A (en) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 Epinastine hydrobromide crystal form II and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102000164B (en) Traditional Chinese medicine composition for treating psoriasis and preparation method thereof
CN103027965A (en) Traditional Chinese medicine combination for treating hemorrhoids and preparation method thereof
CN103393857B (en) Drug for curing hepatitis and preparation method thereof
CN109876058A (en) A kind of pharmaceutical composition and preparation method thereof for treating anaphylactoid purpura
CN106890280A (en) Chinese medicine composition, its extract, preparation method and application, the medicament containing it
CN101890100B (en) Medicament for curing dermatitis and eczema and preparation method thereof
CN104998197A (en) Traditional Chinese medicine composition for treating liver cancer
CN104840623A (en) Traditional Chinese medicine combination for treating toxic heat flourishing type burn and preparation method thereof
CN104027652B (en) A kind of hypoglycemic Chinese medicine prepn and preparation method thereof
CN102335276B (en) Preparation method and application of tree peony extract and composition of tree peony extract
KR101058072B1 (en) Vegetable burn remedies
CN102028919A (en) Application of Tibetan medicine composition to preparing medicament for treating fracture
CN104940635A (en) Scald and burn traditional Chinese medicine compound for external use
CN105944069A (en) Plaster used for treating gynecological diseases and preparation method thereof
CN106038839A (en) Yi-nationality ointment for treating wound infection and suppuration
CN104274708A (en) Traditional Chinese medicine for treating hyperthyroidism
CN105288131A (en) Traditional Chinese medicine decoction for treating renal tuberculosis and preparation method thereof
CN105832915A (en) Chinese herbal preparation for treating duodenal ulcer and preparation method thereof
CN105031516A (en) Chinese herbal unguent for curing erysipelas
CN105267399A (en) Medicine for treating cold-heat jumble symptom of rheumatoid arthritis
CN105012789A (en) Composition for treating cervical cancer and preparation method thereof
CN104173527B (en) A kind of female menstrual period nursing medicament and preparation method thereof
CN103536741B (en) External-use Chinese medicine for prompting anal fistula postoperative recovery
CN103191349A (en) Traditional Chinese medicine preparation for treating nephritis
CN104001049A (en) Traditional Chinese medicine composition for treating urticaria

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 554300 Kaihang Road 238, Chuandong Education Park, Bijiang District, Tongren City, Guizhou Province

Applicant after: tongren university

Address before: 554300 Kaihang Road 238, Chuandong Education Park, Bijiang District, Tongren City, Zunyi City, Guizhou Province

Applicant before: tongren university

CB02 Change of applicant information
WW01 Invention patent application withdrawn after publication

Application publication date: 20190614

WW01 Invention patent application withdrawn after publication